Quick facts
- A hepatitis B surface antigen (HBsAg) test detects the surface antigen of the hepatitis B virus, the marker used to identify current infection.
- In the United States it files under 21 CFR 866.3172, Hepatitis B (B antigen, B surface antigen, Be antigen), at Class II, product code LOM.
- The US special controls require the labelling to state that the assay is not intended for screening blood, plasma, cells or tissue donors.
- In Canada an assay that detects a transmissible agent is an IVDD, and Part 2 Rule 2 of Schedule 1 sends an assay for a serious disease with a risk of propagation to Class III.
- A test used to screen donors for transfusion or transplantation is a different case again: Part 2 Rule 1 sets that use at Class IV.
- Entries, classes and product codes below were checked against the eCFR, the Regulations and the openFDA classification database on 2026-10-12.
Hepatitis B is a blood-borne virus that can persist for life, and the surface antigen is the marker a laboratory uses to tell current infection from past exposure or vaccination. The same word - "HBsAg test" - covers a diagnostic assay used on a patient sample and a donor-screening assay used on donated blood, and the two are not the same device in class terms. In the United States the diagnostic assay is a Class II device whose labelling must disclaim donor screening; in Canada a transmissible-agent assay for a serious disease is Class III, and a donor-screening use is Class IV. This article sets out the routes. The graduated specimen containers on the same bench are ordered with the same consumables list.
What is a hepatitis B surface antigen test?
A hepatitis B surface antigen test is an immunoassay, or a nucleic-acid assay, that detects the surface protein of the hepatitis B virus in serum or plasma. A reactive HBsAg result indicates current infection; it does not distinguish acute from chronic infection on its own, which is why it is read with other markers. Laboratories run it to diagnose infection, to monitor a known case, and - in a different format and setting - to screen donated blood.
That last use is the one to keep separate. A diagnostic assay run on a patient sample answers a clinical question. A donor-screening assay answers a safety question about a unit of blood that may be transfused, and the regulators place it in a different, higher class. The kit is the regulated article in both cases, and its labelling states which use it is for.
Is an HBsAg test Class II in the United States?
Yes. 21 CFR 866.3172 is titled Hepatitis B (B antigen, B surface antigen, Be antigen) and the entry sits at Class II (special controls). The openFDA device classification API lists product code LOM, Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen), under that number.
The special controls are mostly about the label. The regulation requires the labelling to carry a prominent statement that the assay is not intended for the screening of blood, plasma, cells or tissue donors, alongside an explanation of the principles of operation, the interpretation of results and the limitations that must be kept current. Those words are not boilerplate - they are the device's special control, and a laboratory that repurposes a diagnostic kit for donor screening is stepping outside its cleared use.
| Item | Detail |
|---|---|
| US regulation | 21 CFR 866.3172 - Hepatitis B (B antigen, B surface antigen, Be antigen) |
| US class | Class II (special controls) |
| Product code | LOM (Test, Hepatitis B) |
| Named special control | Label must state the assay is not for blood, plasma, cell or tissue donor screening |
| Device type | In vitro diagnostic reagent system |
How does Canada classify an HBsAg test?
Canada treats the kit as an in vitro diagnostic device and applies Part 2 of Schedule 1 of the Medical Devices Regulations. A diagnostic assay that detects the presence of, or exposure to, a transmissible agent is caught by Rule 2. Rule 2 starts at Class II, then raises the class in the listed cases - and one of them is an assay "intended to be used to detect the presence of, or exposure to, a transmissible agent that causes a serious disease where there is a risk of propagation in the Canadian population", which is Class III.
A second route reaches Class III too: Rule 2(b)(iii) covers an assay that detects an infectious agent in cerebrospinal fluid or blood. Hepatitis B is both a serious, transmissible disease and, in a blood-borne sense, an agent detected in blood, so a diagnostic HBsAg assay is Class III in Canada even though the US diagnostic entry is Class II.
| Item | Canada | United States |
|---|---|---|
| Named entry | None; classified by rule | 866.3172, Class II |
| Class (diagnostic use) | Class III (Part 2, Rule 2) | Class II (special controls) |
| Class (donor screening) | Class IV (Part 2, Rule 1) | Different, donor-screening regime |
| Governing text | Schedule 1, Part 2, Rules 1 and 2 | 21 CFR 866.3172 |
| Route to market | Device licence s.32 with ISO 13485 | 510(k) and registration |
Which uses share the same class?
The class follows the claim on the label, not the box design. A diagnostic HBsAg kit is Class II in the United States and Class III in Canada. The same chemistry supplied as a donor-screening assay is Class IV in Canada, because Part 2 Rule 1 covers an assay used to assess blood, blood components, tissues or organs for suitability for transfusion or transplantation.
| Use on the label | Class, Canada | Class, US |
|---|---|---|
| Diagnose or monitor infection | III (Part 2, Rule 2) | II (866.3172) |
| Detect an infectious agent in blood | III (Part 2, Rule 2(b)(iii)) | II (866.3172) |
| Screen donors for transfusion or transplantation | IV (Part 2, Rule 1) | Separate donor-screening regime |
The practical lesson is short. A laboratory must run the assay for the use on its label, and a procurement officer should notice when a supplier offers one chemistry under two different claims - the class can change with the claim even when the reagents do not.
What does Class III mean for the supplier?
A Canadian Class III IVDD needs a device licence under section 32 of the Regulations, built on ISO 13485 quality management, ISO 14971 risk management and analytical performance evidence, with the calibrator value traceable under ISO 17511. In the United States the equivalent gate is a 510(k) carrying the special-control labelling.
A laboratory accredited to ISO 15189 still has to prove the result at its own bench: lot-to-lot verification, control performance and the sample-handling conditions the manufacturer states. The class number does not carry any of that.
Which standards sit behind an HBsAg result?
The Clinical and Laboratory Standards Institute publishes the evaluation and quality-control protocols a laboratory applies to a new immunoassay; ISO 15189 is the accreditation standard for the laboratory itself; ISO 17511 covers calibrator traceability. Where a laboratory is part of a national surveillance programme, the World Health Organization and public-health guidance on hepatitis testing set the reporting expectations.
A clinic laboratory that confirms a reactive HBsAg result also sends it on to public health, because hepatitis B is a reportable disease in every Canadian province. That reporting step is not part of the device class, but it is the reason a laboratory keeps the sample, the result and the lot number together - a reactive result that cannot be tied back to a kit lot is a harder report to defend.
What should the order record say?
Record the marker, the assay format, the intended use on the label (diagnostic or donor screening), the platform, the calibrator and control lots, and the storage condition. Add the class reference - 21 CFR 866.3172 in the United States, Part 2 Rule 2 of Schedule 1 in Canada - and note explicitly which use the kit is licensed for, because that is the line that decides the class.
An infectious-disease bench buys specimen handling and PPE on the same order. Clinics that stock for a whole practice can order through the wholesale programme and request a bulk quote for a standing or annual order; the nitrile examination gloves, 3.5 mil, 1,000 per case sits in the same catalogue. Reselling? become a distributor.
Sources
- openFDA device classification API
- Medical Devices Regulations, SOR/98-282, full text and Schedule 1
- US FDA, overview of device regulation
- US FDA, medical device databases
- Health Canada, medical devices
- Health Canada, establishment licensing
- Clinical and Laboratory Standards Institute
- Public Health Ontario, infection prevention and control
- ISO 15189:2022, medical laboratories — requirements for quality and competence
- ISO 17511:2020, metrological traceability of values assigned to calibrators and control materials
- US CDC, laboratory quality
- World Health Organization
- ISO 13485:2016, medical devices quality management
- ISO 14971:2019, risk management of medical devices
Printable record sheet. An infectious-disease bench keeps a reagent and control log that has to survive an audit. Open the free sterilization log sheet library — the downloadable pack holds a steam-cycle log, a reprocessing-room checklist and an equipment-maintenance sheet. No account and no sign-up; print as many copies as your autoclave log needs.
Log generator. Because a dated log is a dated log, whether it records a sterilizer cycle or a reagent lot. Run the sterilization log generator to build a dated, facility-labelled cycle sheet you can print or file straight into your quality manual.
Ask a compliance specialist. If your laboratory runs transmissible-agent assays and wants the class and the labelling claim explained for your province. Send your question — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.
Related reading
- Rapid strep tests in Canada vs the US: which rules change
- Rapid influenza antigen tests in Canada vs the US: which class applies
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.
Frequently Asked Questions
What does an HBsAg test detect?
It detects the surface antigen of the hepatitis B virus, the marker used to identify current infection rather than past exposure or vaccination.
What class is an HBsAg test in the United States?
Class II (special controls), under 21 CFR 866.3172, with product code LOM. The special control is a label statement that the assay is not for blood, plasma, cell or tissue donor screening.
Why is an HBsAg test Class III in Canada?
Part 2 Rule 2 of Schedule 1 raises the class for an IVDD that detects a transmissible agent causing a serious disease with a risk of propagation, or an infectious agent in blood. A diagnostic hepatitis B assay meets that description.
Is a donor-screening assay in the same class?
No. In Canada an assay used to assess blood, blood components, tissues or organs for suitability for transfusion or transplantation falls under Part 2 Rule 1 and is Class IV.
Does the assay format change the class?
No. An immunoassay and a nucleic-acid assay for the same marker answer the same clinical question; the class follows the claim, not the method.
What else is this test called?
HBsAg, hepatitis B surface antigen, hepatitis B antigen panel and HBV antigen assay are names used for the same family of measurement.